Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — FY26 Annual Report | 28 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Apollo Hospitals reported FY2025-26 consolidated revenue of ₹25,229 crore, EBITDA of ₹3,769 crore, and PAT of ₹1,942 crore, with a proposed final dividend of ₹10 per share.
🔄 What Changed
Revenue grew 13% YoY to ₹25,229 crore; PAT rose 33.1% to ₹1,942 crore; digital health revenue surged to ₹106,693 crore; 42 robotic surgery systems operational; 7,289 pharmacy stores; 78 hospitals nationwide.
🔮 What's Next
Proposed composite scheme of arrangement to merge Apollo Health and Lifestyle Limited with Kids Clinic India Limited; expansion plans for 1,000 new beds in FY26-27 and 8,000 beds by FY30-31; continued focus on AI-driven healthcare and Tier 2/3 city expansion.
💡 Investor Takeaway
Apollo Hospitals is executing a clear growth strategy through digital health expansion, robotic surgery scaling, and geographic diversification into Tier 2/3 cities, supported by strong financials and a proposed dividend, positioning it as a leader in India's integrated healthcare ecosystem.

Apollo Hospitals Enterprise Ltd's FY 2025-26 Annual Report details its integrated healthcare ecosystem, financial performance, and strategic growth initiatives. The company reported consolidated revenue of ₹25,229 crore, EBITDA of ₹3,769 crore, and PAT of ₹1,942 crore, with a proposed final dividend of ₹10 per share. Key growth drivers include expansion into Tier 2/3 cities (e.g., Narendrapur, Sarjapur, Gurugram), 42 robotic surgery systems, 20 AI algorithms, and 7,289 pharmacy stores. The report highlights strong digital health adoption (47 million registered users on Apollo 24|7), 78 hospitals, and 10,970 beds. Material risks include regulatory pressures, foreign exchange volatility, and geopolitical impacts on international patient flows. Governance disclosures confirm board reappointments, ESOP grants (277,234 stock options), and compliance with SEBI regulations. The report also outlines a proposed composite scheme of arrangement to strengthen maternity and fertility services through a merger with Kids Clinic India Limited.

📄 View Original Announcement (PDF)

About Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹1,25,998.49 Cr P/E: 60.3 ROE: 22.9% ROCE: 22.1% Div Yield: 0.23%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day